Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Biochim Biophys Acta Mol Basis Dis ; 1863(11): 2791-2795, 2017 11.
Artigo em Inglês | MEDLINE | ID: mdl-28765075

RESUMO

Defect in the complex I of the mitochondrial electron-transport chain is a characteristic of Parkinson's disease (PD) which is thought to play a critical role in the disease pathogenesis. Mutations in vacuolar protein sorting 35 (VPS35) cause autosomal dominant PD and we recently demonstrated that pathogenic VPS35 mutations cause mitochondrial damage through enhanced mitochondrial fragmentation. In this study, we aimed to determine whether pathogenic VPS35 mutation impacts the activity of complex I and its underlying mechanism. Indeed, VPS35 D620N mutation led to decreased enzymatic activity and respiratory defects in complex I and II in patient fibroblasts. While no changes in the expression of the complex I and II subunits were noted, the level of assembled complex I and II as well as the supercomplex was significantly reduced in D620N fibroblasts. Importantly, inhibition of mitochondrial fission rescued the contents of assembled complexes as well as the functional defects in complex I and II. Overall, these results suggest that VPS35 D620N mutation-induced excessive mitochondrial fission leads to the defects in the assembled complex I and supercomplex and causes bioenergetics deficits.


Assuntos
Complexo I de Transporte de Elétrons/deficiência , Fibroblastos/metabolismo , Mutação de Sentido Incorreto , Doença de Parkinson/metabolismo , Proteínas de Transporte Vesicular/metabolismo , Substituição de Aminoácidos , Complexo II de Transporte de Elétrons/genética , Complexo II de Transporte de Elétrons/metabolismo , Fibroblastos/patologia , Humanos , Doença de Parkinson/genética , Doença de Parkinson/patologia , Proteínas de Transporte Vesicular/genética
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa